Verition Fund Management
AGL icon

Verition Fund Management’s Agilon Health AGL Stock Holding History

Verition Fund Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,214
Closed -$107K – 2233
2025
Q4 		$107K Sell
6,214
-163
-3% -$3.16K ﹤0.01% 3299
2025
Q3 		$164K Sell
6,377
-27
-0.4% -$1.02K ﹤0.01% 3523
2025
Q2 		$368K Buy
+6,404
New +$514K ﹤0.01% 3101
2024
Q4 		– Sell
-5,036
Closed -$495K – 3217
2024
Q3 		$495K Sell
5,036
-40
-0.8% -$5.17K ﹤0.01% 2326
2024
Q2 		$830K Sell
5,076
-6,350
-56% -$905K ﹤0.01% 1789
2024
Q1 		$1.74M Buy
+11,426
New +$1.9M 0.01% 1284
2023
Q3 		– Sell
-656
Closed -$284K – 2311
2023
Q2 		$284K Sell
656
-491
-43% -$276K ﹤0.01% 1594
2023
Q1 		$681K Sell
1,147
-637
-36% -$357K 0.01% 1091
2022
Q4 		$720K Buy
1,784
+1,052
+144% +$493K 0.01% 1071
2022
Q3 		$429K Buy
732
+251
+52% +$150K ﹤0.01% 1995
2022
Q2 		$263K Buy
+481
New +$243K 0.01% 1787
2021
Q3 		– Sell
-344
Closed -$349K – 1860
2021
Q2 		$349K Buy
+344
New +$301K ﹤0.01% 1273

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Verition Fund Management's AGL Position: Q1 2026 in Review

Verition Fund Management sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 6,214 shares — an estimated $107K sold.

Verition Fund Management first reported a position in AGL in Q2 2021 and held it in 12 quarters. The position peaked at $1.74M in Q1 2024. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Verition Fund Management reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 6,214 Agilon Health shares in Q1 2026, an estimated $107K.
  • Verition Fund Management first reported a position in Agilon Health in Q2 2021 and held it in 12 quarters.
  • Verition Fund Management's Agilon Health position peaked at $1.74M in Q1 2024.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.